Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
Peter Zdziarski, Vice President and Marketing Director at Glanzmann’s Research Foundation, shared a post on LinkedIn։
”As a patient with a rare disease, my data is highly valuable.
If you are part of the Glanzmann Thrombasthenia community or the rare disease community at large, yours is too!
Before taking part in one of the many surveys out there, a few things to keep in mind:
- What will happen to your data, how it will be shared, and for how long it will be retained.
This establishes where your data goes and how long it lives outside of your control.
In rare disease communities, even anonymous data can be sensitive and have a long shelf life.
- If ‘strong legal or liability language’ seems out of proportion to a ‘simple survey.’
Legalistic language, disclaimers, or liability notices may indicate a higher risk or more extensive data use than the survey itself suggests.
This should trigger a closer look.
- Who the research partner is and what they gain from the data.
Knowing whether the partner is academic, non-profit, or pharmaceutical can help understand the intent and whether the main advantage is patient-centered, commercial, or a combination of both.
That being said, surveys are important.
When conducted in a transparent and respectful manner, they can increase awareness, inform better research, and give a voice to patients with rare diseases who are often unheard.”
Stay updated with Hemostasis Today.
-
Apr 3, 2026, 17:59A Free Hemoglobin Screening Camp for Kaikadi Vasti and Eramushti Community Women – Hope Foundation Sironcha
-
Apr 3, 2026, 17:53Carlos Henrique Del Carlo: HFpEF and Iron Deficiency – Why Treating the Mitochondrial Engine Matters More Than We Thought?
-
Apr 3, 2026, 17:46Michelle Leona Cecil: A Call to Protect Patient Care and The Nation’s Blood Supply for Blood Disorders Community
-
Apr 3, 2026, 17:38Shahab Sheikhalishahi: A Rare Case of Portal Vein Thrombosis After Echis Carinatus Envenomation
-
Apr 3, 2026, 17:33Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
-
Apr 3, 2026, 17:28Ryan Perry: Heart and Stroke Announces 2026 Grants-in-Aid Indigenous Research Stream Funding Opportunity
-
Apr 3, 2026, 17:21Maxime Dely: A Meaningful Journey of 14 years in Blood Transfusion
-
Apr 3, 2026, 17:19Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
-
Apr 3, 2026, 17:17Louise St. Germain Bannon: Preparating for ISTH 2026 and Highlighting Best Aspects of Congress